Photodynamic therapy with verteporfin: A new treatment in ophthalmology

Seminars in Ophthalmology

Volumn 16, Issue 4, 2001, Pages 201-206

  Michels, Stephan ^a   Schmidt Erfurth, Ursula ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ANGIOGRAPHY; DIABETIC RETINOPATHY; DRUG ACTIVATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; EYE TUMOR; INFUSION; LASER; LASER COAGULATION; LIGHT ABSORPTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION;

CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; OPHTHALMOLOGY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 0035554894     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1076/soph.16.4.201.10298     Document Type: Review

References (48)

1. Further evaluation of the use of hematoporphyrin derivative as a new aid for endoscopic detection of malignant disease
2. Photodynamic therapy of malignant tumours
3. Photodynamic therapy for the treatment of cancer: Current status and advances
4. Photophysical and photobiological processes in the photodynamic therapy of tumours
5. Sites of photosensitization by derivatives of hematoporphyrin
6. Photodynamic therapy of cancer
7. How does photodynamic therapy work?
8. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye
9. Vascular effects of photodynamic therapy
10. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin
11. Preliminary studies on a more effective phototoxic agent than hematoporphyrin
12. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents
13. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization
14. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative
15. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates
16. Lipoprotein receptors and endothelial cells
17. Differences in the uptake of modified low density lipoproteins by tissue cultured endothelial cells
18. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model
19. Clinical pharmacokinetics of verteporfin
20. The clinical status of benzoporphyrin derivative
21. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors
22. Vascular targeting in photodynamic occlusion of subretinal vessels
23. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization
24. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys
25. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin
26. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey
27. Histopathological changes following photodynamic therapy in human eyes
28. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
29. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy
30. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study
31. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study
32. Choroidal changes after photodynamic therapy (PDT). A two-year follow-up study of 38 patients
33. Photodynamic effects on choroidal neovascularization and physiological choroid
34. Chorioretinal anastomosis as unfavourable prognostic factor during photodynamic therapy
35. A prospective randomized trial comparing the standard reqimen in photo-dynamic therapy (PDT) to earlier/less frequent retreatments
36. Sub-tenon's retrobulbar anecortave acetate with and without Visudyne™ photodynamic therapy (PDT) in patients with subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD)
37. Early vascular changes induced by photodynamic therapy using verteporfin
38. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP Report 1
39. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials - TAP Report 2
40. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Three-year results of an open-label extension of 2 randomized clinical trials - TAP Report No. 6
41. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin In Photodynamic Therapy Report 2
42. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-Year results of a randomized clinical trial - VIP Report No. 1
43. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes
44. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: Two-year results of a randomized clinical trial - VIP Report #3
45. Photodynamic therapy: Expanded indication
46. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: One-year results of an uncontrolled, prospective case series
47. Photodynamic therapy in large choroidal hemangioma: A long-term evaluation